Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.

Lappas, Courtney M

Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation. [electronic resource] - Journal of leukocyte biology Feb 2010 - 345-54 p. digital

Publication Type: Journal Article

1938-3673

10.1189/jlb.0609388 doi


Acute Disease
Adenosine A2 Receptor Agonists
Animals
Antigens, CD--immunology
CD4-Positive T-Lymphocytes--immunology
CD8-Positive T-Lymphocytes--immunology
Cyclohexanecarboxylic Acids--pharmacology
Cytokines--immunology
Disease Models, Animal
Female
Gene Expression Regulation--drug effects
Graft vs Host Disease--drug therapy
Hematopoietic Stem Cell Transplantation
Mice
Purines--pharmacology
Receptor, Adenosine A2A--immunology
Transplantation, Homologous